Updated Jul 16, 2026 · Last SEC filing 2026-06-08
Aurinia Pharmaceuticals Inc. (AUPH) has filed 8 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-08. 3 Form 8-K material event filings were reported by AUPH in the last 90 days. 6 Form 144 notices of proposed sale were filed for AUPH stock. InsiderAlpha tracks every AUPH SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001600620 |
|---|
| Form 4 filings (90d) | 8 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 6 |
| Latest Form 4 filing | 2026-06-08 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | Chief Executive Officer | P — Open-market purchase | 206.0K | $15.28 | $3.15M | SEC | |
| TANG KEVIN | Chief Executive Officer | P — Open-market purchase | 99 | $15.34 | $2K | SEC | |
| TANG KEVIN | Chief Executive Officer | P — Open-market purchase | 343.5K | $15.28 | $5.25M | SEC | |
| TANG KEVIN | Chief Executive Officer | P — Open-market purchase | 262.7K | $15.31 | $4.02M | SEC | |
| TANG KEVIN | Chief Executive Officer | P — Open-market purchase | 2.3K | $15.35 | $35K | SEC | |
| Cole Ryan | Chief Operating Officer | A — Grant or award | 116.1K | $0.00 | — | SEC | |
| Robertson Stephen P. | Chief Legal Officer | A — Grant or award | 115.5K | $0.00 | — | SEC | |
| Hearne Michael S | Chief Financial Officer | A — Grant or award | 116.1K | $0.00 | — | SEC | |
| Keenan Greg | SVP, Chief Medical Officer | F — Tax withholding / forfeiture | 8.1K | $14.32 | $116K | SEC | |
| TANG KEVIN | Insider | P — Open-market purchase | 184.2K | $14.22 | $2.62M | SEC | |
| Miller Joseph M | Chief Financial Officer | F — Tax withholding / forfeiture | 37.5K | $14.21 | $533K | SEC | |
| Greenleaf Peter | Chief Executive Officer | F — Tax withholding / forfeiture | 100.9K | $14.21 | $1.43M | SEC | |
| TANG KEVIN | Insider | P — Open-market purchase | 115.8K | $14.21 | $1.65M | SEC | |
| Robertson Stephen P. | EVP, General Counsel | F — Tax withholding / forfeiture | 36.5K | $14.21 | $519K | SEC | |
| Donley Matthew Maxwell | Chief Operating Officer | F — Tax withholding / forfeiture | 40.8K | $14.21 | $579K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Aurinia Pharmaceuticals Inc. (AUPH). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| TANG KEVIN | 6 | $12.47M |
| Hearne Michael S | 2 | — |
| Cole Ryan | 2 | — |
| Bailey Jeffrey Allen | 1 | — |
| Robertson Stephen P. | 1 | — |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in AUPH insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live AUPH dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.